Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Accumulated Expenses for 3 consecutive years, with $2.8 million as the latest value for Q1 2026.

  • Quarterly Accumulated Expenses fell 78.82% to $2.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Jan 2026, down 78.82% year-over-year, with the annual reading at $2.3 million for FY2025, 885.04% up from the prior year.
  • Accumulated Expenses for Q1 2026 was $2.8 million at Kestra Medical Technologies, down from $15.5 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $15.5 million in Q4 2025, with the low at $234000.0 in Q2 2024.
  • Average Accumulated Expenses over 3 years is $6.0 million, with a median of $2.5 million recorded in 2025.
  • The sharpest move saw Accumulated Expenses skyrocketed 885.04% in 2025, then crashed 78.82% in 2026.
  • Over 3 years, Accumulated Expenses stood at $234000.0 in 2024, then skyrocketed by 6521.37% to $15.5 million in 2025, then tumbled by 82.18% to $2.8 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $2.8 million, $15.5 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.